Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Class II alloantigen expression on leukemic cells.

A Falkenrodt1, A Urlacher, S Mayer

  • 1Centre Régional de Transfusion Sanguine, Strasbourg, France.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The challenge of replicating putative genetic risk factors in a population-based database.

Journal of gastroenterology and hepatology·2024
Same author

Full aperture backscatter diagnostics for characterization of laser plasma instabilities at the extreme light infrastructure (ELI) beamlines.

The Review of scientific instruments·2023
Same author

Swept-source optical coherence tomography microsystem with an integrated Mirau interferometer and electrothermal micro-scanner.

Optics letters·2018
Same author

Retroperitoneal primitive neuroectodermal tumor (PNET): case report and review of literature.

European journal of gynaecological oncology·2018
Same author

Ultra-broadband EPR spectroscopy in field and frequency domains.

Physical chemistry chemical physics : PCCP·2018
Same author

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.

Oncoimmunology·2018
Same journal

XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts.

Nouvelle revue francaise d'hematologie·1995
Same journal

Improved detection of CD2 on formaldehyde-fixed non dehydrated cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.

Nouvelle revue francaise d'hematologie·1995
Same journal

Allogeneic transplantation of peripheral blood progenitor cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Selection and expansion of CD34+ cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

Nouvelle revue francaise d'hematologie·1995
See all related articles

Class II antigen expression on leukemia cells differs when studied with monoclonal antibodies versus alloantisera. This reactivity variation depends on the specific leukemic cell type, impacting diagnostic approaches.

Area of Science:

  • Immunology
  • Hematology

Background:

  • Class II antigen expression on leukemic cells is typically assessed using monoclonal antibodies (Mabs).
  • Class II antigen polymorphism is conventionally studied using alloantisera.

Purpose of the Study:

  • To investigate discrepancies in Class II antigen detection on leukemic cells using Mabs versus alloantisera.
  • To determine if reactivity patterns vary across different leukemic cell lineages.

Main Methods:

  • Comparative analysis of leukemic cell reactivity.
  • Utilizing both monoclonal antibodies and alloantisera for Class II antigen detection.

Main Results:

  • Reactivity of leukemic cells with Class II Mabs did not consistently match results obtained with alloantisera.

Related Experiment Videos

  • Observed variations in Class II antigen detection were dependent on the specific leukemic cell type.
  • Conclusions:

    • Monoclonal antibodies and alloantisera provide different insights into Class II antigen expression on leukemic cells.
    • Leukemic cell lineage is a critical factor influencing Class II antigen detection methods.